Pages that link to A Prospective, Multi-centre, Open label, Single arm Study to Evaluate the Efficacy and Safety of Amlapitta Mishran Suspension in Participants with Amlapitta (Symptomatic Gastritis)

Primary tabs

Cite This Article

Vancouver Style ::
Koli PG, Shetty Y, Sharma R, Sevatkar BK, Pathrikar AA, Paradkar HS, et al. A Prospective, Multi-centre, Open label, Single arm Study to Evaluate the Efficacy and Safety of Amlapitta Mishran Suspension in Participants with Amlapitta (Symptomatic Gastritis). Pharmacognosy Journal. 2025;17(5):545-551.PDF icon PDF (504.97 KB)
No backlinks found.

Copyright © 2020 Pharmacogn J. All rights reserved.

Pharmacognosy Journal and its contents are licensed under a Creative Commons Attribution-Non Commercial-No Derivs 4.0 License. Permissions beyond the scope of this license may be available with  editor@phcogj.com